Abstract
Aberrant expression of transmem-brane mucins promotes tumor progression and interferes with im-munological and medicinal elimina-tion of cancer cells. In a recent article, Pedram et al. directed an at-tenuated bacterial mucin-specific protease to HER2-positive tumor cells and observed decreased tumor growth rates and extended survival of mice bearing HER2-positive tumors.
Original language | English |
---|---|
Pages (from-to) | 755-757 |
Number of pages | 3 |
Journal | Trends in Pharmacological Sciences |
Volume | 44 |
Issue number | 11 |
Early online date | 5 Sep 2023 |
DOIs | |
State | Published - Nov 2023 |
All Science Journal Classification (ASJC) codes
- Toxicology
- Pharmacology